Mutual Fund Details
NAV
₹13.7500
as on 10 Jul 2020, 11:30 PM
₹0.1100(0.81%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹100
Suggested Date
15th of Every Month
Investment Performance
would have given a return of
₹103,499
₹106,749
₹139,937
₹141,899
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹41,899
Profit (absolute return)
41.90%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
15.16%
In the last 6 months
28.03%
In the last 1 year
41.90%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend Payout
as of 31 May 2020, 05:30 AM
₹1,460.01 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 15 days.
0.80%
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 15 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 May 2020
Healthcare
86.72%
₹1,266.15 Cr
Cash Holding
8.23%
₹120.17 Cr
Financial
2.60%
₹38.03 Cr
Chemicals
1.68%
₹24.49 Cr
Companies Holding in this Mutual Fund
as on 31 May 2020
Cipla Ltd.
12.21%
₹178.27 Cr
Sun Pharmaceutical Inds. Ltd.
10.33%
₹150.82 Cr
Lupin Ltd.
8.34%
₹121.76 Cr
Others
8.28%
₹120.89 Cr
Biocon Ltd.
5.73%
₹83.66 Cr
JB Chemicals & Pharmaceuticals Ltd.
4.12%
₹60.15 Cr
Cadila Healthcare Ltd.
4.11%
₹60.01 Cr
Sanofi India Ltd.
3.99%
₹58.25 Cr
Natco Pharma Ltd.
3.71%
₹54.17 Cr
Divi's Laboratories Ltd.
3.25%
₹47.45 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 May 2020
Cipla Ltd.
12.21%
₹178.27 Cr
Sun Pharmaceutical Inds. Ltd.
10.33%
₹150.82 Cr
Lupin Ltd.
8.34%
₹121.76 Cr
Others
8.28%
₹120.89 Cr
Biocon Ltd.
5.73%
₹83.66 Cr
JB Chemicals & Pharmaceuticals Ltd.
4.12%
₹60.15 Cr
Cadila Healthcare Ltd.
4.11%
₹60.01 Cr
Sanofi India Ltd.
3.99%
₹58.25 Cr
Natco Pharma Ltd.
3.71%
₹54.17 Cr
Divi's Laboratories Ltd.
3.25%
₹47.45 Cr
View All
View All
This fund's returns:
41.90%Return Duration
1 Year
DSP Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
24.91%
34.98%
1Y Returns
45.58
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
24.91%
34.98%
1Y Returns
45.17
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
24.91%
34.98%
1Y Returns
41.90
SBI Healthcare Opportunities Fund Direct Plan - Growth
EquityPharma
Min. Investment
₹500
Category Returns
24.91%
34.98%
1Y Returns
38.24
Nippon India Pharma Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
24.91%
34.98%
1Y Returns
37.50
About ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend Payout
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend Payout is a Equity mutual fund scheme from ICICI Prudential Mutual Fund. This scheme was launched on 13 Jul 2018 and is currently managed by its fund manager Dharmesh Kakkad. It has an AUM of ₹1,460.01 Crores and the latest NAV decalared is ₹13.750 as on 11 Jul 2020 at 3:54 pm.
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend Payout scheme return performance in last 1 year is 41.90%, is 38.89% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹1,460.01 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 13 Jul 2018 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
AMC Information
ICICI Prudential Mutual Fund
View AMC Details
₹337,234.81 Cr
AUM
233
Schemes
Address
One BKC , A Wing ,13th Floor, Bandra Kurla Complex,400051
Phone Number
Phone : 022-26525000 / 1800-222-999 / 1800-200-6666
Fax : 022-26528100
Email / Website
